 NEW YORK, Sept. 20, 2021 PRNewswire -- Actinium Pharmaceuticals, Inc. NYSE AMERICAN: ATNM Actinium or the Company, a leader in the development of targeted radiotherapies for patients with unmet needs, today announced that it will present at four upcoming investor conferences. 